L'Università degli Studi dell'Insubria è una università statale italiana fondata nel 1998 a Varese con sede nelle città di Varese e Como. Prende il nome dall'area geografica in cui sono situate le sedi.

During the past decade, Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese" #1 collaborator was "Impact Biomedicines, Inc., a wholly owned subsidiary of Celgene Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese" are "Myelofibrosis" (2 trials), "Primary Myelofibrosis" (2 trials), "Anemia" (1 trials), "Leukemia, Myeloid, Acute" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese" in a lesser frequency.

Most popular intervention types in "Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ACE-536" (1 trials), "Azacitidine" (1 trials), "Best Available Therapy (BAT)" (1 trials), "Durvalumab" (1 trials) and "FEDRATINIB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universita degli Studi dell'Insubria - Ospedale di Circolo e Fondazione Macchi - Varese, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".